LUMIRA VENTURES
With a 30-year reputation as a leading North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meeting significant unmet needs and creating transformation impact in communities worldwide. Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States.
LUMIRA VENTURES
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Information Technology Medical Medical Device Pharmaceutical Therapeutics Venture Capital
Founded:
1989-01-01
Status:
Active
Contact:
416.213.4223
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache
Similar Organizations
ABC Compounding Pharmacy
ABC Compounding Pharmacy is guaranteed to meet and exceed your expectations by providing quality service at low convenient pricing.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Chicago Prostate Cancer Center
Specialize in the diagnosis treatment of prostate cancer with radiation seed implants. #Brachytherapy #Prostate #Cancer
Chugai Pharma USA
Chugai Pharma USA is a healthcare based pharmaceutical firm providing products and services for the benefit of patients.
HealthWright Technologies
HealthWright Technologies is a healthcare service provider & pharmaceutical firm that provides healthcare technology & patient services.
InVitro Select
Innovative system to increase the success rate of vitro fertilization (IVF) by selecting the most viable sperm for the procedure.
Leo Universal
Leo Universal is a Chinese company that engaged in coal processing, logistic transportation networks and childhood education.
NeoProteomics
NeoProteomics provides research services and tools that help clients unravel the complexities of pharmaceutical and biological research.
Orion Modern
An innovative healthcare venture capital firm. Genetics, pharma and wider biotech. America & Asia HQ. Founded in 2010.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Plexigen
Plexigen is a biotechnology company that provides genetic and proteomic testing services.
PTM BioLab
PTM Biolab addresses the need for life sciences and personalized medicine, by the creation and supply of innovative technologies.
Current Advisors List
Advisor
Advisor
Advisor
Current Employees Featured
Gerry Brunk, MBA Managing Director @ Lumira Ventures
Managing Director
2002-01-01
Baye Galligan, M.A., HBA Associate @ Lumira Ventures
Associate
2021-04-01
Brent Norton Venture Partner @ Lumira Ventures
Venture Partner
2016-07-01
Lu Han, Ph.D. Director, Business Development Asia Pacific @ Lumira Ventures
Director, Business Development Asia Pacific
2014-01-01
Peter van der Velden, MBA, M.Sc. Managing General Partner @ Lumira Ventures
Managing General Partner
2007-03-01
Benjamin Rovinski, Ph.D. Managing Director @ Lumira Ventures
Managing Director
2001-01-01
Richard Glickman Venture Partner @ Lumira Ventures
Venture Partner
2017-04-01
Jacki Jenuth Partner @ Lumira Ventures
Partner
2001-01-01
Nikhil Thatte Principal @ Lumira Ventures
Principal
2019-03-01
Dahlia Abbott Accounting / Office Manager @ Lumira Ventures
Accounting / Office Manager
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-30 | X4 Pharmaceuticals | Lumira Ventures investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
2022-02-08 | Congruence Therapeutics | Lumira Ventures investment in Series A - Congruence Therapeutics | 63 M CAD |
2021-12-16 | Specific Biologics | Lumira Ventures investment in Seed Round - Specific Biologics | N/A |
2021-12-09 | OncoMyx Therapeutics | Lumira Ventures investment in Series B - OncoMyx Therapeutics | 50 M USD |
2021-12-08 | Viron Inc. | Lumira Ventures investment in Series B - Viron Inc. | 50 M USD |
2021-11-03 | Antios Therapeutics | Lumira Ventures investment in Series B - Antios Therapeutics | 75 M USD |
2021-11-02 | Antiva Biosciences | Lumira Ventures investment in Series D - Antiva Biosciences | 31 M USD |
2021-10-29 | Deka Biosciences | Lumira Ventures investment in Series A - Deka Biosciences | 20 M USD |
2021-08-10 | Thryv Therapeutics | Lumira Ventures investment in Series A - Thryv Therapeutics | 19 M USD |
2021-05-20 | BioTheryX | Lumira Ventures investment in Series E - BioTheryX | 92 M USD |
Newest Events participated

More informations about "Lumira Ventures"
Life Sciences Venture Capital Firm - About Lumira Ventures
Lumira Ventures Fund IV (US$222M;C$295M) Angelini Lumira Biosciences Strategic Fund (US$35M;C$47M) The Lumira Foundation. The mission of the Lumira Foundation is to support …See details»
Biotech Venture Capital Firm | Toronto - Lumira Ventures
Lumira Ventures invests in top-tier biotech and medtech companies. We are a life sciences venture capital firm with offices in Toronto, Montreal, and Vancouver. Leadership includes Lu …See details»
The Terry Fox Foundation and Lumira Ventures Partner to Launch …
Apr 10, 2025 A first-of-its-kind collaboration in Canada between a philanthropic organization and a venture capital firm with a mission to invest in best-in-class cancer-focused companies. …See details»
Lumira Ventures - Crunchbase Investor Profile
With a 30-year reputation as a leading North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, Lumira Ventures collaborates with and invests in entrepreneurial …See details»
Lumira Ventures, Author at Life Sciences British Columbia
Lumira Ventures. Silver Sponsor. Website www.lumiraventures.com; Phone +1 (604) 558 5156 Email info@lumira.vc; Address 141 Adelaide Street West Toronto, ON M5H 3L5; Leadership …See details»
Lumira Ventures and Terry Fox Foundation Partner to Launch The …
May 7, 2025 Lumira Ventures and the Terry Fox Foundation closed the market at the Toronto Stock Exchange to celebrate the official launch of the Cancer Breakthrough Fund. This …See details»
Lumira Ventures IV - Venture Ontario
Lumira Ventures IV is a North American focused venture capital fund focused on investing in transformative healthcare and life sciences companies. Fund IV is being deployed using a …See details»
Lumira Ventures III - Venture Ontario
Lumira Ventures is a later stage VC which partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies. Lumira invests in companies developing innovative …See details»
Lumira Capital Investment Portfolio | Life Sciences - Lumira Ventures
Explore Lumira Ventures investment portfolio and discover the innovative biotech, medtech, and life sciences companies we partner with. As a leading Canadian VC firm with offices in …See details»
Lumira Ventures Closes on US$255 Million of New Capital to Build ...
Jul 26, 2021 Lumira Ventures today announced a significant expansion of its capital base to support the founding and building of innovative healthcare companies in Canada and the U.S. …See details»
Lumira Ventures to launch hedge fund targeting public biotech firms
Talking point: Lumira is mirroring a strategy adopted by some U.S. biotech investors, which have long backed both public and private companies. It is one of Canada’s largest biotech investors …See details»
Lumira Ventures Leadership Team | Biotech Venture Capital Firm
Lumira Ventures invests in top-tier biotech and medtech companies. We are a life sciences venture capital firm with offices in Toronto, Montreal, and Vancouver. Leadership includes Lu …See details»
Venture Capital Firms: 700 Top Venture Capital Companies - Fundz
Lumira Ventures - Ontario, CA. McLean Watson Capital Inc. - Ontario, CA. Mercator Investments Limited - Ontario, CA. Merchant Advance Capital - British Columbia, CA. ... Northwestern …See details»
Lumira Ventures closes $276 million fund IV to back health care …
Jul 26, 2021 Lumira Ventures closes $276 million fund IV to back health care companies It’s Lumira’s largest fund to date, and the firm believes it’s the largest institutional life sciences …See details»
Home - BIOTECanada
5 days ago BIOTECanada BIOTECanada Congratulates Liberal Party on Election Victory. At a time of global economic uncertainty and shifting geopolitical dynamics, this mandate presents …See details»
$190M Raised: Canada's Top 20 Moonshot Venturesâ„¢ of
5 days ago Canada’s Top 20 Moonshots Ventures™ of 2025 are shaped by the insight and leadership of NACO’s national member network. These organizations—spanning angel …See details»
Omega Venture Partners Team: World-Class Leadership
World-class leadership team strategically investing in early-growth AI innovators, delivering strategic AI investments and industry-leading outcomes.See details»
The Terry Fox Foundation and Lumira Ventures Partner to Launch …
Apr 10, 2025 A first-of-its-kind collaboration in Canada between a philanthropic organization and a venture capital firm with a mission to invest in best-in-class cancer-focused companies. …See details»
Lumira Ventures Announces Promotion of Suman Rao to Principal
Jan 10, 2025 Lumira Ventures, a leading North American life sciences investment firm dedicated to advancing healthcare innovation and enhancing patient outcomes, is pleased to announce …See details»
Woodbridge Ventures II enters into letter of intent with …
Woodbridge Ventures II Inc., a capital pool company as defined under TSX Venture Exchange Policy 2.4 – Capital Pool Companies , has entered into a non-binding letter of intent dated May …See details»